On June 8, 2022 Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, reported that Dr. Joseph Tucker, Chief Executive Officer of Enveric, will participate in three upcoming conferences (Press release, Enveric Biosciences, JUN 8, 2022, View Source [SID1234615758]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A.G.P.’s Summer Healthcare Conference

Gravitas’ 3rd Los Angeles Summit

H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond

For more information about the conference, or to schedule a one-on-one meeting with Enveric’s management team, please contact your appropriate representatives, or send an email to A.G.P. at [email protected], Gravitas at [email protected], H.C. Wainwright at [email protected] or KCSA Strategic Communications at [email protected].